Picture of Rohto Pharmaceutical logo

4527 — Rohto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Rohto -9-MTH group results

Feb 9 (Reuters)-  
             Rohto Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2015        Dec 31, 2014     Mar 31, 2016  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales              120.32              107.46           167.50     
                   (+12.0 pct)         (+4.2 pct)       (+10.4 pct)  
  Operating           11.86                9.00            15.10     
                   (+31.7 pct)         (-31.5 pct)      (+14.7 pct)  
  Recurring           12.22                9.64            15.10     
                   (+26.7 pct)         (-28.2 pct)      (+7.1 pct)   
  Net                  7.81                5.85             9.50     
                   (+33.5 pct)         (-28.6 pct)      (+10.1 pct)  
  EPS               68.69 yen           51.54 yen        83.57 yen   
  EPS Diluted       68.40 yen           51.32 yen                    
  Ann Div                               19.00 yen        20.00 yen   
  -Q2 div           10.00 yen           9.00 yen                     
  -Q4 div                               10.00 yen        10.00 yen   
   
  NOTE - Rohto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Rohto Pharmaceutical

See all news